Raleigh, NC – July 8, 2024 – uMethod Health, a trailblazer in precision medicine and personalized health solutions, proudly announces the appointment of Dr. Ida Crocker-Sabbagh as its Chief Medical Officer (CMO). Dr. Crocker-Sabbagh's extensive clinical expertise and groundbreaking work in Alzheimer's disease prevention elevate uMethod Health's commitment to transforming patient care through innovative technology and personalized care plans. With a distinguished career spanning over three decades, Dr. Crocker-Sabbagh specializes…READ MORE

John Q Walker, Ph.D., the Co-founder, and Chief Technology Officer of uMethod Health, recently participated in a distinguished panel of experts in the field of disease. The discussion centered around translating technological advancements into actionable strategies at a clinical level. Together, the panel delved into the realm of proactive, precision, and holistic medicine, identifying it as the next frontier in healthcare. Dr. Walker describes how uMethod is at the forefront…READ MORE

Nearly half (48.1%) of American adults have high blood pressure (HBP, or hypertension). However, many are unaware of the problem, which often causes no symptoms. This situation is very dangerous. HBP damages the heart and blood vessels and causes strokes. It’s a leading cause of kidney failure. Hypertension is even a major risk factor for Alzheimer's disease and related dementias (ADRD). The combination of HBP and sleep apnea is particularly…READ MORE

Michael K. Racke, MD, medical director of neurology at Quest Diagnostics, delved into some commonly-believed myths about Alzheimer disease and provided his insight on the scientific explanations for these assumptions. Common myths:#1: Only older patients need to worry about AD. #2: AD is primarily an inherited genetic disease. #3: Most patients don’t want to know if they are at risk of developing AD. #4: Only high-powered imaging tests can help evaluate for AD. #5: Only…READ MORE

Raleigh-based uMethod was founded in 2013 to help doctors treat patients suffering from cognitive problems like dementia and Alzheimer’s. The SaaS platform provides a service to doctors, who order blood tests for a patient suffering from cognitive decline in order to create a personalized AI-generated care plan.  AI collects data on patients from blood tests ordered by their doctor and devises a treatment plan by analyzing treatable causes such as infection, inflammation,…READ MORE

RESEARCH TRIANGLE PARK –  Alzheimer’s Disease and dementia have long been feared by many, especially those with first-hand experience. Vik Chandra, CEO and co-founder of uMETHOD is familiar with this disease having seen it in both his grandmother and mother-in-law. According to Chandra, there are 17 and a half million Medicare-aged patients somewhere on a spectrum of cognitive decline, and about 150,000 doctors across the country caring for these patients. He is passionate…READ MORE

Quest Diagnostics recently announced the nationwide availability of the RestoreU Dementia Panel, an artificial intelligence (AI)-based risk assessment and care service created by uMETHOD Health. In this video interview, Dr. Michael K. Racke, medical director for neurology at Quest Diagnostics, spoke to Stephen Wellman, director of content and strategy at LabPulse and The Science Advisory Board, about the challenges associated with identifying those who do not have Alzheimer's and may…READ MORE

Secaucus, NJ and Raleigh, NC – May 4, 2023 – Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced nationwide availability of the RestoreU™ Dementia Panel, a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. The RestoreU service employs artificial intelligence…READ MORE

In February 2022, Dr. Federico Canavosio of Integrative Medical Care (IMC) in Vero Beach, FL started applying a new approach to memory care for patients aged 60 and older. IMC began working with medical AI company uMETHOD Health to deploy RestoreU, an evidence-based care program for patients at risk of developing Alzheimer’s Disease (AD), dementia, or other cognitive issues. “Cognitive impairment and related dementias are difficult to treat because they…READ MORE

Despite our annual expressions of gratitude to our veterans for all they’ve sacrificed, we fall short when it comes to their health and well-being. In addition to cancer, diabetes, and mental-health disorders, veterans suffer from Alzheimer’s Disease (AD) and other forms of dementia at high rates. Veterans currently under a physician’s care need a comprehensive workup and a care plan that addresses the factors that drive the progression of AD.…READ MORE